CUAMC
China Universal Asset Management Company’s Ascendis Pharma ASND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.1M | Buy |
12,186
+73
| +0.6% | +$12.6K | 0.2% | 106 |
|
|
2025
Q1 | $1.89M | Sell |
12,113
-676
| -5% | -$105K | 0.18% | 113 |
|
|
2024
Q4 | $1.76M | Buy |
12,789
+1,647
| +15% | +$227K | 0.16% | 112 |
|
|
2024
Q3 | $1.66M | Buy |
11,142
+4,338
| +64% | +$648K | 0.18% | 107 |
|
|
2024
Q2 | $928K | Sell |
6,804
-4,216
| -38% | -$575K | 0.13% | 108 |
|
|
2024
Q1 | $1.67M | Buy |
11,020
+4,385
| +66% | +$663K | 0.21% | 91 |
|
|
2023
Q4 | $836K | Buy |
6,635
+5,173
| +354% | +$652K | 0.16% | 120 |
|
|
2023
Q3 | $137K | Buy |
1,462
+714
| +95% | +$66.9K | 0.04% | 172 |
|
|
2023
Q2 | $66.8K | Sell |
748
-23
| -3% | -$2.05K | 0.02% | 173 |
|
|
2023
Q1 | $82.7K | Buy |
771
+204
| +36% | +$21.9K | 0.03% | 134 |
|
|
2022
Q4 | $69.2K | Buy |
567
+47
| +9% | +$5.74K | 0.03% | 129 |
|
|
2022
Q3 | $54K | Buy |
+520
| New | +$54K | 0.02% | 122 |
|